Sarcoma felino posvacunal (FISS), reporte de caso en Colombia
Feline postvaccinal sarcoma (FISS), case report in Colombia
DOI:
https://doi.org/10.15446/rfmvz.v69n2.103266Keywords:
adyuvante, felino, hidróxido de aluminio, leucemia, neoplasia, virus (es)adjuvant, feline, aluminum hydroxide, leukemia, neoplasm, virus (en)
Downloads
El sarcoma felino posvacunal o sarcoma de sitio de inyección (FISS) en una neoplasia poco descrita en felinos en Colombia, se presenta posterior al uso de vacunas inactivas con adyuvante. El objetivo fue describir la presencia de un sarcoma felino posterior a la vacunación con leucemia felina virus inactivo, primer caso documentado en Colombia. Un felino, macho, mestizo, de 7 años de edad, esterilizado, vacunado con leucemia felina inactiva desde hace 3 años, desarrolla un nódulo de 5 cm de diámetro en la región dorsal, firme y no doloroso. En dermis profunda y músculo estriado, se evidencia proliferación neoplásica de células fusiformes, de crecimiento principalmente expansivo y en menor medida invasivo, que se organiza y forma haces cortos y fascículos largos que se entrecruzan, con focos densos y laxos y en focos se dispone en un patrón de espina de pescado. Las células presentan morfología fusiforme, ligeramente ovoide, irregular, algunas redondeadas, con citoplasma eosinófilo tenue e intenso en otros focos más densos. Se evidencia pleomorfismo celular y anisocitosis moderadas. Los núcleos presentan morfología redonda, ovoide e irregular. Se evidencia la presencia de uno o más nucléolos en algunas de sus células, cromatina principalmente granular fina, pleomorfismo nuclear y anisocariosis moderada. Se contabilizaron 4 mitosis en 10 campos con el objetivo de alto poder en 2,37 mm2, no se observa aparente invasión linfovascular, se evidencia compromiso de bordes laterales. Adicionalmente, discretos focos de necrosis multifocal < 50%, infiltrado inflamatorio mixto polimorfonuclear, neutrófilos moderados multifocales e infiltrado mononuclear linfocítico multifocal.
Feline postvaccinal sarcoma, or injection site sarcoma (FISS), is a poorly described neoplasm in felines in Colombia that occurs after the use of inactive vaccines with adjuvant. The objective of this report is to describe the presence of a feline sarcoma after vaccination with inactive feline leukemia virus, the first case documented in Colombia. A 7-year-old male, mestizo, sterilized feline, vaccinated with inactive feline leukemia for 3 years, develops a 5 cm diameter nodule in the dorsal region, firm and painless. In deep dermis and striated muscle, there is evidence of neoplastic proliferation of spindle cells, of mainly expansive growth and to a lesser extent invasive, organizing and forming short bundles and long bundles that intersect, with dense and lax foci and in foci it is arranged in a pattern of fishbone . The cells have a fusiform, slightly ovoid, irregular morphology, some rounded, with tenuous and intense eosinophilic cytoplasm in other denser foci. Cellular pleomorphism and moderate anisocytosis are evident. The nuclei present round, ovoid, and irregular morphology. The presence of one or more nucleoli is evidenced in some of its cells, mainly fine granular chromatin, nuclear pleomorphism and moderate anisokaryosis. 4 mitoses were recorded in 10 fields with the high-power objective of 2,37 mm2, no apparent lymphovascular invasion was observed, there was evidence of involvement of the lateral borders. Additionally, discrete multifocal necrosis foci < 50%, mixed polymorphonuclear inflammatory infiltrate with moderate multifocal neutrophils and multifocal lymphocytic mononuclear infiltrate.
References
Almimira J, Villafranca M. 1998. Oncología cutánea. Canis et felis. 32 :10-46.
Beato M. 1997. Condrosarcoma en el cubito y radio de un gato. Caso clínico. AVEPA. 17(4): 207-209. Disponible en: https://core.ac.uk/reader/33160390
Bowlt K. 2015. Feline injection site associated sarcomas. In practice. 37(1): 2-11. https://doi.org/10.1136/inp.h65 DOI: https://doi.org/10.1136/inp.h65
Bregazzi VS, Larue SM, McNeil E, Macy DW, Dernell WS, Powers BE, Withrow SJ. 2001. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000). JAVMA. 218(4): 547-550. https://doi.org/10.2460/javma.2001.218.547 DOI: https://doi.org/10.2460/javma.2001.218.547
Buracco P, Martano M, Morello E, Ratto A. 2002. Vaccine- associated- like fibrosarcoma at the site of a deep non-absorbable suture in a cat. The V eterinary J ournal. 163(1):105-107. https://doi.org/10.1053/tvjl.2001.0617 DOI: https://doi.org/10.1053/tvjl.2001.0617
Carminato A, Vascellari M, Marchioro W, Melchiotti E, Mutinelli F. 2011. Microchip-associated fibrosarcoma in a cat. Veterinary D ermatology. 22(6): 565-569. https://doi.org/10.1111/j.1365-3164.2011.00975.x DOI: https://doi.org/10.1111/j.1365-3164.2011.00975.x
Carwardine D, Friend E, Toscano E, Bowlt K. 2014. Owner preferences for treatment of feline injection site sarcomas. Journal of Small Animal Practice. 55(2): 84-88. https://doi.org/10.1111/jsap.12162 DOI: https://doi.org/10.1111/jsap.12162
Couto SS, Griffey SM, Duarte PC, Madewell BR. 2002. Feline vaccine-associated fibrosarcoma: morphologic distinctions. Veterinary Pathology. 39(1): 33-41. https://journals.sagepub.com/doi/pdf/10.1354/vp.39-1-33 DOI: https://doi.org/10.1354/vp.39-1-33
Davidson EB, Gregory CR, Kass PH. 1997. Surgical excision of soft tissue fibrosarcomas in cats. Veterinary Surgery. 26(4): 265-269. https://doi.org/10.1111/j.1532-950x.1997.tb01497.x DOI: https://doi.org/10.1111/j.1532-950X.1997.tb01497.x
Day MJ, Schoon HA, Magnol JP, Saik J, Devauchelle P, Truyen U, Thibault JC. 2007. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine. 25: 4073-4084. https://doi.org/10.1016/j.vaccine.2007.02.049 DOI: https://doi.org/10.1016/j.vaccine.2007.02.049
Day MJ, Horzinek MC, Schultz RD. 2010. WSAVA guidelines for the vaccination of dogs and cats. Journal of the Small Animal Practice. 51: 338-356. https://doi.org/10.1111%2Fjsap.2_12431 DOI: https://doi.org/10.1111/j.1748-5827.2010.00959.x
Daly MK, Saba CF, Crochik SS, Howerth EW, Kosarek CE, Cornell KK, Northrup NC. 2008. Fibrosarcoma adjacent to the site of microchip implantation in a cat. Journal of Feline Medicine and Surgery. 10(2): 202-205. http://dx.doi.org/10.1016/j.jfms.2007.10.011 DOI: https://doi.org/10.1016/j.jfms.2007.10.011
Dobson JM, Demetriou JL. 2014. Skin tumors. China: Saunders Elsevier. 768 p. DOI: https://doi.org/10.1016/B978-0-7020-4336-9.00020-2
Doddy FD, Glickman LT, Glickman NW, Javovitz EB. 1996. Feline fibrosarcomas at Vaccination Sites and Non- vaccination Sites. Journal of Comparative Pathology. 114(2): 165-174. https://doi.org/10.1016/s0021-9975(96)80005-3 DOI: https://doi.org/10.1016/S0021-9975(96)80005-3
Ellis JA, Jackson ML, Bartsch RC, McGill LG, Martin KM, Trask BR, Haines DM. 1996. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. JAVMA. 209(4): 767-771. https://pubmed.ncbi.nlm.nih.gov/8756876/
Folgearini MS, Bonel JS, Machado P, Gevehr CF. 2015. Sarcomas de tejidos blandos en caninos y felinos: aspectos epidemiológicos y patológicos. Rev Ciencias Veterinarias. 31(2): 7-12. Disponible en: https://documentop.com/sarcoma-de-tejidos-blandos-en-caninos-y-felinos-north-american-_59f874ca1723dd96965cf9aa.html
Gobar GM, Kass PH. 2002. World Wide Web-based survey of vaccination practices postvaccinal reactions, and vaccine-site associated sarcomas in cats. JAVMA. 220(10): 1477-1482. https://doi.org/10.2460/javma.2002.220.1477 DOI: https://doi.org/10.2460/javma.2002.220.1477
Giudice C, Stefanello D, Sala M, Cantatore M, Russo F, Romussi S, Grieco V. 2010. Feline injection-site sarcoma: recurrence, tumour grading and surgical margin status evaluated using the three dimensional histological technique. The Veterinary Journal. 186(1): 84-88. https://doi.org/10.1016/j.tvjl.2009.07.019 DOI: https://doi.org/10.1016/j.tvjl.2009.07.019
Hauck M. 2003. Feline injection site sarcomas. Vet Clin Small Anim. 33(3): 553-571. https://doi.org/10.1016/s0195-5616(03)00006-8 DOI: https://doi.org/10.1016/S0195-5616(03)00006-8
Hartmann K, Day MJ, Thiry E, Lloret A, Frymus T, Addie D. 2015. European Advisory Board on Cat Diseases. Feline injection site sarcoma: ABCD guidelines on prevention a management. Journal of Feline Medicine and Surgery. 17(7): 606-613. https://doi.org/10.1177/1098612x15588451 DOI: https://doi.org/10.1177/1098612X15588451
Hendrick MJ, Goldschmidt MH, Shofer FS, Wang YY, Somlyo AP. 1992. Postvaccinal sarcomas in the cat: Epidemiology and electron probe microanalytical identification of aluminum. Cancer Research. 52(19): 5391-5394. https://pubmed.ncbi.nlm.nih.gov/1394143/
Hendrick MJ, Brooks JJ. 1994. Postvaccinal sarcomas in the cat: histology and immunohistochemistry. Veterinary Pathology. 31(1): 126-129. https://doi.org/10.1177/030098589403100121 DOI: https://doi.org/10.1177/030098589403100121
Hershey AE, Sorenmo KU, Hendrick MJ, Shofer FS, Vail DM. 2000. Prognosis for presumed feline vaccine associated sarcoma after excision: 61 cases (1986-1996). JAVMA. 216(1): 58-61. https://doi.org/10.2460/javma.2000.216.58 DOI: https://doi.org/10.2460/javma.2000.216.58
Hill J, Lawrence J, Saba C, Turek M, Feldhaeusser B, Coutermarsh S, Gogal RJr. 2014. In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line. Research in Veterinary Science. 97(2): 349-357. https://doi.org/10.1016/j.rvsc.2014.07.006 DOI: https://doi.org/10.1016/j.rvsc.2014.07.006
Kass PH, Barnes WG, Spangler WL, Chomel BB, Culbertson MR. 1993. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. JAVMA. 203(3): 396-405. https://pubmed.ncbi.nlm.nih.gov/8257557/
Kass PH, Spangler WL, Hendrick MJ, McGill LD, Esplin DG, Slater M, Decile K. 2003. Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats. JAVMA. 223(9): 1283-1292. https://doi.org/10.2460/javma.2003.223.1283 DOI: https://doi.org/10.2460/javma.2003.223.1283
Kirpensteijn J. 2006. Feline injetion site-associated sarcoma: ¿Is it a reason to critically evaluate our vaccination polices? Journal of V .117(1): 59-65. https://doi.org/10.1016/j.vetmic.2006.04.010 DOI: https://doi.org/10.1016/j.vetmic.2006.04.010
Kliczkowska K, Jankowska U, Jagielski D, Czopowicz M, Sapierzynski R. 2015. Epidemiological and morphological analysis of feline injection site sarcomas. Journal of Veterinary Sciences. 18(2): 313- 322. https://doi.org/10.1515/pjvs-2015-0041 DOI: https://doi.org/10.1515/pjvs-2015-0041
Lester S, Clemett T, Burt A. Ladlow J. 2013. Injection site associated sarcoma in the cat treatment recommendations and results to date. Journal of Feline Medicine and Surgery. 15(2): 409-418. https://doi.org/10.1177/1098612x13483239 DOI: https://doi.org/10.1177/1098612X13483239
Liptak JM, Forrest LJ. 2013. Soft tissue sarcomas. En: Withrow S, Vail D, Page R. Small Animal Clinical Oncology. Quinta edición . St Louis. Saunders. p. 425-454. DOI: https://doi.org/10.1016/B978-072160558-6.50023-X
London CA, Hannah AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Cherrington JM. 2003. Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clinical Cancer Research. 9(7): 2755-2768. https://pubmed.ncbi.nlm.nih.gov/12855656/
Macy DW. 1999. Current understanding of vaccination site-associated sarcomas in the cat. Journal of Feline Medicine and Surgery. 1(1): 15-21. https://doi.org/10.1016/s1098-612x(99)90005-0 DOI: https://doi.org/10.1016/S1098-612X(99)90005-0
Macy DW, Hendrick MJ. 1996. The potential role of inflammation in the development of postvaccinal sarcomas in cats. Vet Clin Small Anim. 26(1): 103-109. https://doi.org/10.1016/S0195-5616(96)50009-4 DOI: https://doi.org/10.1016/S0195-5616(96)50009-4
Magden E, Quckenbush SL, Vandewoude S. 2011. FIV associated neoplasms-A mini Review. Veterinary Immunology and Immunopathology. 143(3): 227-234. https://doi.org/10.1016/j.vetimm.2011.06.016 DOI: https://doi.org/10.1016/j.vetimm.2011.06.016
Martano M, Morello E, Buracco P. 2011. Feline injection-site sarcoma: Past, present and future perspectives. Veterinary Journal. 188(2): 136-141. https://doi.org/10.1016/j.tvjl.2010.04.025 DOI: https://doi.org/10.1016/j.tvjl.2010.04.025
Martano M, Morello E, Lussich S, Buracco P. 2012. A case of feline injection-site sarcoma at the site of cisplatin injections. Journal of Feline Medicine and Surgery. 14(10): 751-754. https://doi.org/10.1177/1098612x12449407 DOI: https://doi.org/10.1177/1098612X12449407
McLeland SM, Imhoff DJ, Thomas M, Powers BE, Quimby JM. 2013. Subcutaneous fluid port-associated soft tissue sarcoma in a cat. Journal of Feline Medicine and Surgery. 15(10): 917-920. https://doi.org/10.1177/1098612x13478267 DOI: https://doi.org/10.1177/1098612X13478267
Miller MA, Aper RL, Fauber A, Blevins WE, Ramos-Vara JA. 2006. Extraskeletal osteosarcoma associated with retained surgical sponge in a dog. Journal of Veterinary Diagnostic Investigation. 18(2): 224-228. https://doi.org/10.1177/104063870601800218 DOI: https://doi.org/10.1177/104063870601800218
Morrison WB, Starr RM. 2001. Vaccine-Associated Feline Sarcoma Task Force: Vaccine-associated feline sarcomas. JAVMA. 218(5): 697-702.
Molina VM. 2013. Linfoma mediastínico por leucemia viral felina. J. Agr. Anim. Sci. 2(1): 80-86. https://doi.org/10.2460/javma.2001.218.697 DOI: https://doi.org/10.2460/javma.2001.218.697
Morris J, Dobson J. 2001. Small Animal Oncology. Estados Unidos: Editorial Offices. 304 p. DOI: https://doi.org/10.1002/9780470690406
Nagell M. 1998. Fibrosarkome der Katze. Prakt Tierarzt. 79: 600-606. Disponible en: https://www.fellomed.de/katzenkrankheit/fibrosarkom-katze/
Nelson RW, Couto GC. 2020. Small Animal Internal Medicine. Sexta edición . Estados Unidos: St Louis. Elsevier. 1504 p.
Nimwegen V, Kirpensteijn J. 2012. Specific disorders. En: Veterinary Surgery Small Animal. Estados Unidos: Ed. M. Johnston, S. A. Tobias. Saunders. 765 p.
Phelps HA, Kuntz CA, Milner RJ, Powers BE, Bacon NJ. 2011. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002). JAVMA. 239(1): 97-106. https://doi.org/10.2460/javma.239.1.97 DOI: https://doi.org/10.2460/javma.239.1.97
Pool RP, Carrig CB. 1972. Multiple cartilagenous exostoses in a cat. Veterinary Pathology. 9: 350-359. http://dx.doi.org/10.1177/030098587200900505 DOI: https://doi.org/10.1177/030098587200900505
Richards JR, Elston TH, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Sparkes AH. 2006. The 2006 American Association of Feline Practitioners feline vaccine advisory panel report. JAVMA. 229(9): 1405-1441. https://doi.org/10.2460/javma.229.9.1405 DOI: https://doi.org/10.2460/javma.229.9.1405
Romanelli G, Marconato L, Olivero D, Massari F, Zini, E. 2008. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). JAVMA. 232(8): 1193-1199. https://doi.org/10.2460/javma.232.8.1193 DOI: https://doi.org/10.2460/javma.232.8.1193
Scherk MA, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Lappin MR, Sparkes AH. 2013. AAFP Feline Vaccination Advisory Panel Report. Journal of Feline Medicine and Surgery. 15(9): 785-808. https://doi.org/10.1177/1098612x13500429 DOI: https://doi.org/10.1177/1098612X13500429
Séguin B. 2002. Injection site sarcomas in cats. Clinical Techniques in Small Animal Practice. 32(4): 983-985. https://doi.org/10.1053/svms.2002.36605 DOI: https://doi.org/10.1016/S0195-5616(02)00022-0
Skorupski KA, Shaw SC, Kent MS, Gordon IK, Collins CJ, Greasby TA, Beckett LA. 2009. Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990- 2006). JAVMA. 234(3): 376-380. https://doi.org/10.2460/javma.234.3.376 DOI: https://doi.org/10.2460/javma.234.3.376
Sinkovics JG. 2007. Adult human sarcomas. I. Basic science. Expert Review of Anticancer Therapy. 7(1): 31-56. https://doi.org/10.1586/14737140.7.1.31 DOI: https://doi.org/10.1586/14737140.7.1.31
Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982–1993) 1996. JAAHA. 32(2): 91–95. https://doi.org/10.5326/15473317-32-2-91 DOI: https://doi.org/10.5326/15473317-32-2-91
Vascellari M, Melchiotti E, Bozza MA, Mutinelli F. 2003. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline postvaccinal fibrosarcomas. JAVMA. 50(6): 286-291. https://doi.org/10.1046/j.1439-0442.2003.00544.x DOI: https://doi.org/10.1046/j.1439-0442.2003.00544.x
Woodward K. 2011. Origins of injection- site sarcomas in cats: the possible role of chronic inflammation- A Review. ISRN Veterinary Science. 10: 1-16. http://dx.doi.org/10.5402/2011/210982 DOI: https://doi.org/10.5402/2011/210982
How to Cite
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Download Citation
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Facultad de Medicina Veterinaria y de Zootecnia, Universidad Nacional de Colombia.
Copying and citation of materials that appear in the Journal are authorized as long as a clear statement indicates the journal title, author(s) name(s), year of publication, volume, and the number of pages of the article cited.